0001144204-12-052936.txt : 20120926 0001144204-12-052936.hdr.sgml : 20120926 20120926060304 ACCESSION NUMBER: 0001144204-12-052936 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120921 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120926 DATE AS OF CHANGE: 20120926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dehaier Medical Systems Ltd CENTRAL INDEX KEY: 0001474627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34661 FILM NUMBER: 121110106 BUSINESS ADDRESS: STREET 1: SUITE 501, JIUZHOU PLAZA STREET 2: 83 FUXING ROAD, CITY: HAIDIAN DISTRICT, BEIJING STATE: F4 ZIP: 100856 BUSINESS PHONE: (8610) 5166-0080 MAIL ADDRESS: STREET 1: SUITE 501, JIUZHOU PLAZA STREET 2: 83 FUXING ROAD, CITY: HAIDIAN DISTRICT, BEIJING STATE: F4 ZIP: 100856 8-K 1 v324259_8k.htm CURRENT REPORT

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of report (date of earliest event reported): September 21, 2012

  


 

DEHAIER MEDICAL SYSTEMS LIMITED

 (Exact name of registrant as specified in its charter)

 

British Virgin Islands   001-34661   Not Applicable

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

Suite 501, Jiuzhou Plaza

83 Fuxing Road, Haidian District

Beijing 100856 China

(Address of principal executive offices, including zip code)

 

+86 (10) 5166-0080

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 8.01.          Other Events.

 

On September 21, 2012, the Registrant issued a press release announcing that it had entered into a procurement agreement with a Ukrainian medical device manufacturer, by which the Registrant’s air compressors, customized trolleys and accessories may be sold in Ukraine and Europe through the manufacturer’s sales network.

 

A copy of the press release announcing the agreement is attached hereto as Exhibit 99.1.

 

Item 9.01.          Financial Statements and Exhibits.

 

(d)Exhibits.

 

99.1Press release dated September 21, 2012, titled “Dehaier Medical Wins Three Year Procurement Agreement from Major Ukrainian Medical Equipment Manufacturer.”

 

2
 

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Dehaier Medical Systems Limited
     
  By: /s/ Ping Chen
    Ping Chen
    Chief Executive Officer

 

Dated: September 25, 2012

 

3

 

EX-99.1 2 v324259_ex99-1.htm PRESS RELEASE

 

Exhibit 99.1

 

Dehaier Medical Wins Three Year Procurement Agreement from Major Ukrainian Medical Equipment Manufacturer

 

BEIJING, Sept. 21, 2012 /PRNewswire-FirstCall/ — Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has won a 3-year procurement agreement for Dehaier's proprietary air compressors and customized trolleys from a major medical equipment manufacturer in Ukraine.

 

During the three-year term of the agreement, the purchaser will procure Dehaier's proprietary air compressors, customized trolleys and accessories, which will be used in hospital intensive care units, emergency rooms, operation rooms, respiratory departments and anesthesiology departments. The purchaser plans to distribute Dehaier products in Ukraine and other European markets through its sales network.

 

"Since early 2012, Dehaier has made considerable progress in exploring Europe market, mainly due to the grant of CE certification for our air compressor product," noted Ms. Rayna Dong, Director of Dehaier's International Marketing. "By actively partnering with distributors, exploring OEM opportunities and attending leading medical equipment exhibitions, we have begun to see the gradual increase of Dehaier's brand recognition and awareness in Europe.  Dehaier's reputation as a reliable vendor that produces a full line of high quality medical equipment products at reasonable prices enables us to deliver comprehensive, customized solutions to our customers who have to satisfy diverse consumer demands for health care."

 

About Dehaier Medical Systems Ltd.

 

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, nine software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn

 

Forward-looking Statements

 

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the procurement agreement from Ukrainian manufacturer. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

 

 
 

 

Contact Us

 

Dehaier Medical Systems Limited  Surie Liu  +86 10-5166-0080  lius@dehaier.com.cn

 

Dehaier Medical Systems Limited  Tina He  +86 10-5166-0080  hexw@dehaier.com.cn